Gene · 9846
Papers1,533
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,533
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disseminated Xanthogranuloma Harboring a GAB2::BRAF Fusion and MITF Pathogenic Variant Successfully Treated With Cobimetinib: A Rare Case Report. | J Cutan Pathol | 2026 | 42813601 | PubTator, text mining | PubMed |
| Micellar curcumol reprograms tumor-associated macrophages and reverses PARP inhibitor resistance in recurrent ovarian cancer. | Phytomedicine | 2026 | 42365697 | PubTator, text mining | PubMed |
| Genetic Analysis of Acral Melanomas From Southern African Patients. | Pigment Cell Melanoma Res | 2026 | 42290081 | PubTator, text mining | PubMed |
| Integrative Genomic and Epigenomic Dissection of Facial Morphology in Chinese Populations. | Genomics Proteomics Bioinformatics | 2026 | 42266000 | PubTator, text mining | PubMed |
| Genomic Survey of Selection Footprints in Three Buffalo Breeds from Eastern Europe. | Animals (Basel) | 2026 | 42193820 | PubTator, text mining | PubMed |
| A risk scoring model for lung squamous cell carcinoma based on epithelial-mesenchymal transition-related genes: an integrative analysis of prognosis and immune infiltration characteristics. | PeerJ | 2026 | 42089102 | PubTator, text mining | PubMed |
| GAB3 suppresses lung adenocarcinoma progression by inhibiting the MAPK signaling and potentiating CD8+ T cell immunity. | Cancer Lett | 2026 | 42031161 | PubTator, text mining | PubMed |
| Ginsenoside-Rh2 inhibits U251 glioma cell migration and invasion via the Gab2/Akt2 pathway. | Front Oncol | 2026 | 41994641 | PubTator, text mining | PubMed |
| Antibody screening for tumor and immune hotspot targets: The frontier of new methods and technologies. | J Pharm Anal | 2026 | 41798069 | PubTator, text mining | PubMed |
| Physalin A Suppresses Human Oral Squamous Carcinoma Cell Migration and Invasion Through Inhibiting Grb2/Ras and MMP/uPA Signaling Pathways. | In Vivo | 2026 | 41760308 | PubTator, text mining | PubMed |
| Chromosome 3p Deletion Leads to Extensive Genomic Alterations in Diverse Cancers and Confers Synthetic Lethality in Uveal Melanoma. | Cancers (Basel) | 2026 | 41749941 | PubTator, text mining | PubMed |
| Molecular features in gangliogliomas: a systematic review. | Childs Nerv Syst | 2026 | 41721014 | PubTator, text mining | PubMed |
| Ancestry and somatic profile indicate acral melanoma origin and prognosis. | Nature | 2026 | 41708869 | PubTator, text mining | PubMed |
| Cisplatin disrupts OCT1-DNMT1-piRNA epigenetic regulatory axis to suppress GAB2-mediated aggressiveness in OSCC. | Arch Biochem Biophys | 2026 | 41638543 | PubTator, text mining | PubMed |
| [Retracted] MicroRNA‑302a targets GAB2 to suppress cell proliferation, migration and invasion of glioma. | Oncol Rep | 2026 | 41170780 | PubTator, text mining | PubMed |
| Hyperlipidemia-associated specific modules and hub genes revealed by integrative methods of WGCNA and MetaDE. | Front Genet | 2025 | 41446394 | PubTator, text mining | PubMed |
| Hypoxia-induced HIF-1α enhanced the tumorigenesis in non-small cell lung cancer by targeting GAB2. | Mutat Res | 2025 | 41075383 | PubTator, text mining | PubMed |
| Correlation between ultrasonographic features and molecular markers of cancer cell proliferation, invasion, and apoptosis in young patients with advanced breast cancer. | J Obstet Gynaecol Res | 2025 | 40963247 | PubTator, text mining | PubMed |
| DBN1‑mediated upregulation of GAB2 facilitates the migration and invasion of T‑cell acute lymphoblastic leukemia cells. | Oncol Rep | 2025 | 40910271 | PubTator, text mining | PubMed |
| Targeting TRPV6/CXCR4 complexes prevents castration-resistant prostate cancer metastasis to the bone. | Signal Transduct Target Ther | 2025 | 40908300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9846/papers